Publication Correction
Cross-source consensus on Publication Correction from 1 sources and 5 claims.
1 sources · 5 claims
How it works
Risks & contraindications
Comparisons
Background
Highlighted claims
- BMJ Open issued a correction for the LUMO study article, specifically addressing the wording of the study design in the title. — Correction: Does luteal phase support in MOH-IUI treatment improve cumulative live birth rates in couples with unexplained subfertility? Study protocol of the LUMO study: a multicentre, randomised, double-blind, controlled trial with cost-effectiveness analysis
- The original title incorrectly described the study as 'a centre, randomised, double-blind, controlled trial' rather than a multicentre trial. — Correction: Does luteal phase support in MOH-IUI treatment improve cumulative live birth rates in couples with unexplained subfertility? Study protocol of the LUMO study: a multicentre, randomised, double-blind, controlled trial with cost-effectiveness analysis
- The error in the title arose because the word 'multi' was omitted, leaving 'a centre' as the erroneous description of the study structure. — Correction: Does luteal phase support in MOH-IUI treatment improve cumulative live birth rates in couples with unexplained subfertility? Study protocol of the LUMO study: a multicentre, randomised, double-blind, controlled trial with cost-effectiveness analysis
- The correction was limited to the study design description in the title and did not affect other parts of the article. — Correction: Does luteal phase support in MOH-IUI treatment improve cumulative live birth rates in couples with unexplained subfertility? Study protocol of the LUMO study: a multicentre, randomised, double-blind, controlled trial with cost-effectiveness analysis
- The article has been updated since first publication to reflect the corrected multicentre description. — Correction: Does luteal phase support in MOH-IUI treatment improve cumulative live birth rates in couples with unexplained subfertility? Study protocol of the LUMO study: a multicentre, randomised, double-blind, controlled trial with cost-effectiveness analysis